HOME > BUSINESS > Article

Text Size

small

medium

large


Astellas to Buy U.S. Genetic Medicine Developer Audentes

Astellas to Buy U.S. Genetic Medicine Developer Audentes

   Tokyo, Dec. 3 (Jiji Press)--Astellas Pharma Inc. <4503> said Tuesday that it will buy U.S. genetic medicine developer Audentes Therapeutics Inc. for some 3 billion dollars.
   The Japanese company hopes to complete the acquisition of the San Francisco-based company through a tender offer by the end of March next year.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Major Opposition Parties Forgo Non-Confidence Motion against Abe Cabinet
ECONOMY
Tokyo Stocks (Closing): Nikkei Average 23,430.70 (+76.30)
SPORTS
Japan's Takanashi Comes 3rd in Women's World Cup Ski Jumping in Lillehammer
OTHER
Caroll Spinney, Puppeteer behind Sesame Street's Big Bird, Dies at 85

Aomori Tourism Information

GOSHOGAWARA
Introduction of Tachineputa, Town of Kanagi and West Tsugaru Peninsula
・ GOSHOGAWARA 1
・ GOSHOGAWARA 2
・ GOSHOGAWARA 3
JOMON
An early culture with pottery
・ JOMON 1
・ JOMON 2
・ JOMON 3
・ JOMON 4

AFP-JIJI PRESS NEWS JOURNAL


Photos